Search hospitals > Michigan > Warren

Saint John Macomb-Oakland Hospital

Claim this profile
Warren, Michigan 48093
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Recurrence
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
318 reported clinical trials
7 medical researchers
Photo of Saint John Macomb-Oakland Hospital in WarrenPhoto of Saint John Macomb-Oakland Hospital in WarrenPhoto of Saint John Macomb-Oakland Hospital in Warren

Summary

Saint John Macomb-Oakland Hospital is a medical facility located in Warren, Michigan. This center is recognized for care of Cancer, Lung Cancer, Recurrence, Breast Cancer, Adenocarcinoma and other specialties. Saint John Macomb-Oakland Hospital is involved with conducting 318 clinical trials across 455 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.

Area of expertise

1Cancer
Global Leader
Saint John Macomb-Oakland Hospital has run 126 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Lung Cancer
Global Leader
Saint John Macomb-Oakland Hospital has run 51 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Saint John Macomb-Oakland Hospital

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Bladder Cancer
Gastric Cancer
Bladder Carcinoma
Gastroesophageal Junction Adenocarcinoma
Pancreatic Cancer
Adenocarcinoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Saint John Macomb-Oakland Hospital?
Saint John Macomb-Oakland Hospital is a medical facility located in Warren, Michigan. This center is recognized for care of Cancer, Lung Cancer, Recurrence, Breast Cancer, Adenocarcinoma and other specialties. Saint John Macomb-Oakland Hospital is involved with conducting 318 clinical trials across 455 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Saint John Macomb-Oakland Hospital located?
**Ascension Macomb-Oakland Hospital Locations:** - **Warren Campus:** 11800 Twelve Mile Rd, Warren, MI 48093 - **Madison Heights Campus:** 27351 Dequindre Rd, Madison Heights, MI 48071
Who should I call to ask about financial aid or insurance network?
For Saint John Macomb-Oakland Hospital's financial assistance and insurance inquiries, please use the following contact numbers: - **Financial Assistance:** 800-494-5797 - **Billing and Payment:** - Ascension St. John: 877-809-6191 - Ascension Providence: 800-878-2455 - Ascension River District: 810-329-5318 - Ascension Macomb/Oakland: 877-809-6191 For specific questions or concerns, please contact the hospital directly.
What insurance does Saint John Macomb-Oakland Hospital accept?
Ascension Macomb-Oakland Hospital, also known as Saint John Macomb-Oakland Hospital, accepts various insurance plans, including Priority Health, Blue Cross Blue Shield, AARP (UnitedHealthcare) Medicare, Health Alliance Plan (HAP), McLaren Health Plan, and MediGold/Trinity Health Plan of MI. These plans cover a wide range of services, from preventive care to specialized treatments. It is important to confirm benefit coverage with your insurance company before scheduling an appointment and consult your health plan for any referral or authorization requirements.
What awards or recognition has Saint John Macomb-Oakland Hospital received?
Ascension Macomb-Oakland Hospital, located in Warren, Michigan, is an accredited teaching hospital featuring more than 20 training programs and hosting approximately 240 residents and fellows. It has been recognized for its significant contributions to improving outcomes for Americans suffering from heart disease and stroke.